Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

AMARIA, RODABE N

One or more keywords matched the following items that are connected to AMARIA, RODABE N

Item Type	Name
Concept	Melanoma
Concept	Melanoma, Experimental
Academic Article	Therapeutic options in cutaneous melanoma: latest developments.
Academic Article	Dabrafenib in the treatment of advanced melanoma.
Academic Article	Dabrafenib for the treatment of melanoma.
Academic Article	Novel therapies in melanoma.
Academic Article	Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.
Academic Article	Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
Academic Article	Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
Academic Article	Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.
Academic Article	Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
Academic Article	Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
Academic Article	Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Academic Article	Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
Academic Article	Adjuvant peginterferon alfa-2b therapy in stage III melanoma
Academic Article	Correlation between early ¹⁸F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma
Academic Article	Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
Academic Article	Clinicopathological features and clinical outcomes associated with TP53 and BRAF^N ^on- ^V ⁶⁰⁰ mutations in cutaneous melanoma patients
Academic Article	Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
Academic Article	A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
Academic Article	The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.
Academic Article	The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
Academic Article	HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
Academic Article	Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Academic Article	Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma.
Academic Article	Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Academic Article	Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.
Academic Article	Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
Academic Article	Update on use of aldesleukin for treatment of high-risk metastatic melanoma.
Academic Article	A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
Academic Article	Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
Academic Article	Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
Academic Article	Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
Academic Article	RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in Melanoma.
Academic Article	Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
Academic Article	Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall.
Academic Article	Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Academic Article	Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Academic Article	Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
Academic Article	A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling.
Academic Article	Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.
Academic Article	Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade.
Academic Article	Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
Academic Article	Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
Academic Article	Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
Academic Article	Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials.
Academic Article	Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma.
Academic Article	Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Academic Article	Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Academic Article	Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Academic Article	B cells and tertiary lymphoid structures promote immunotherapy response.
Academic Article	Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
Academic Article	Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
Academic Article	Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Academic Article	Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Academic Article	Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Academic Article	The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
Academic Article	Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era.
Academic Article	Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study.
Academic Article	Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
Academic Article	Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
Academic Article	Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Academic Article	Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.
Academic Article	Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
Academic Article	Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Academic Article	Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
Academic Article	Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020.
Academic Article	Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.
Academic Article	Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Academic Article	Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021.
Academic Article	Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Academic Article	Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
Academic Article	Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression.
Academic Article	Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Academic Article	Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Academic Article	Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift.
Academic Article	Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Academic Article	Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.

Search Criteria

Melanoma